Modified-orientation log to assess hepatic encephalopathy

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 8, 2012, Pages 913-920

  Salam, M ^a   Matherly, S ^a   Farooq, I S ^a   Stravitz, R T ^a   Sterling, R K ^a   Sanyal, A J ^a   Gibson, D P ^a   Wade, J B ^a   Thacker, L R ^a   Heuman, D M ^a   Fuchs, M ^a   Puri, P ^a   Luketic, V ^a   Bickston, S J ^a   Bajaj, J S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; LACTULOSE; RIFAXIMIN;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN INJURY; CLINICAL ASSESSMENT TOOL; CONCURRENT VALIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISCRIMINANT VALIDITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MODIFIED ORIENTATION LOG; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; WEST HAVENT CRITERIA;

FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 84858799429     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05038.x     Document Type: Article

References (19)

1. Bajaj JS, Wade JB, Sanyal AJ,. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009; 50: 2014-21.
2. Teasdale G, Jennett B,. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2: 81-4.
3. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
4. Bajaj JS, Cordoba J, Mullen KD, et al,. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33: 739-47.
5. Blei AT, Cordoba J,. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.
6. Novack T,. The Center for Outcome Measurement in Brain Injury. Available at:. Accessed January 2010.
7. Dowler RN, Bush BA, Novack TA, Jackson WT,. Cognitive orientation in rehabilitation and neuropsychological outcome after traumatic brain injury. Brain Inj 2000; 14: 117-23.
8. Jackson WT, Novack TA, Dowler RN,. Effective serial measurement of cognitive orientation in rehabilitation: the Orientation Log. Arch Phys Med Rehabil 1998; 79: 718-20.
9. Novack TA, Dowler RN, Bush BA, Glen T, Schneider JJ,. Validity of the Orientation Log, relative to the Galveston Orientation and Amnesia Test. J Head Trauma Rehab 2000; 15: 957-61.
10. Bajaj JS,. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 2010; 31: 537-47.
11. Cordoba J,. New assessment of hepatic encephalopathy. J Hepatol 2011; 54: 1030-40.
12. Amodio P, Montagnese S, Gatta A, Morgan MY,. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-67.
13. O'Keeffe E, Mukhtar O, O'Keeffe ST,. Orientation to time as a guide to the presence and severity of cognitive impairment in older hospital patients. J Neurol Neurosurg Psychiatry 2011; 82: 500-4.
14. Bajaj JS, Schubert CM, Heuman DM, et al,. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-40.
15. Riggio O, Ridola L, Pasquale C, et al,. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 181-3.
16. Bass NM, Mullen KD, Sanyal A, et al,. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071-81.
17. Hassanein T, Blei AT, Perry W, et al,. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol 2009; 104: 1392-400.
18. Hassanein TI, Hilsabeck RC, Perry W,. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci 2008; 53: 529-38.
19. Ortiz M, Cordoba J, Doval E, Jacas C, Pujadas F, Esteban R, et al,. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007; 26: 859-67.